Deans' stroke musings: Memantine may not be covered through Medicare Part D

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, November 25, 2015

Memantine may not be covered through Medicare Part D

From alz.org;

Memantine coverage

Memantine, which recently became available as a generic drug, may not be covered through Medicare Part D. If you or someone you know is taking memantine, check with your plan to inquire about coverage, or contact your State Health Insurance Program (SHIP) through Medicare and ask to speak to a counselor. You may also want to talk to your doctor regarding your options.

You probably don't have to worry about this because I'm 100% positive that the research from July 2015 suggesting possible use for stroke has never been followed up on. I blame our fucking failures of stroke associations for that.

Study of the neuroprotective effects of memantine in patients with mild to moderate ischemic stroke July 2015

Our results reveal that memantine added to standard treatment of CTEE(cerebral thromboembolic event) could result in a remarkable decrease in the NIHSS confirming improvement of the neurological function of the patients.

No comments:

Deans' stroke musings